Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001093184 | SCV001250040 | uncertain significance | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001093184 | SCV003251224 | benign | not provided | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002557968 | SCV003709333 | likely benign | Inborn genetic diseases | 2022-09-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV003132224 | SCV003812847 | uncertain significance | PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome | 2020-12-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001093184 | SCV005189137 | uncertain significance | not provided | criteria provided, single submitter | not provided |